Enzyme Inhibitors | 酶抑制剂

📚 Enzyme Inhibitors | 酶抑制剂

Enzyme inhibitors are molecules that reduce or abolish the catalytic activity of enzymes. In A‑level Biology, understanding how inhibitors work is fundamental for grasping metabolic control, drug action, and the principles of enzyme kinetics. This article explores reversible and irreversible inhibition, competitive and non‑competitive mechanisms, end‑product inhibition, and how to interpret kinetic data using Michaelis–Menten and Lineweaver–Burk plots.

酶抑制剂是能够降低或消除酶催化活性的分子。在A‑level生物学中，理解抑制剂的作用机制是掌握代谢调控、药物作用以及酶动力学原理的基础。本文探讨可逆与不可逆抑制、竞争性与非竞争性机制、末端产物抑制，以及如何利用米氏方程和莱恩威弗‑伯克图解读动力学数据。

1. What are Enzyme Inhibitors? | 什么是酶抑制剂？

An enzyme inhibitor is any substance that binds to an enzyme and decreases its activity without destroying the enzyme’s primary structure. Inhibitors may be natural regulatory metabolites or artificially synthesised chemicals. In the laboratory, inhibitor studies help reveal the active site architecture and the catalytic mechanism of enzymes. In medicine, many drugs work as specific enzyme inhibitors, making this topic highly relevant to pharmacology.

酶抑制剂是指任何与酶结合并降低其活性、但又不破坏酶一级结构的物质。抑制剂既可以是天然的调控性代谢物，也可以是人工合成的化学物质。在实验室中，抑制剂研究有助于揭示酶的活性位点结构及其催化机制。在医学上，许多药物本身就是特异性的酶抑制剂，使得该主题与药理学密切相关。

2. Reversible vs Irreversible Inhibition | 可逆与不可逆抑制

Inhibitors can be classified according to the permanence of their binding. Reversible inhibitors bind non‑covalently (hydrogen bonds, hydrophobic interactions, ionic bonds) and can dissociate from the enzyme. Irreversible inhibitors usually form covalent bonds with functional groups in the active site, permanently inactivating the enzyme. Heavy metal ions such as Hg²⁺ or Pb²⁺ and the nerve gas sarin are classic examples of irreversible inhibitors.

抑制剂可根据结合的持久性进行分类。可逆抑制剂通过非共价键（氢键、疏水作用、离子键）结合，并能从酶上解离。不可逆抑制剂通常与活性位点内的官能团形成共价键，使酶永久失活。重金属离子如Hg²⁺或Pb²⁺以及神经毒气沙林就是不可逆抑制剂的经典实例。

Reversible inhibition is further divided into competitive, non‑competitive and uncompetitive modes, although the Cambridge International A‑level syllabus focuses mainly on competitive and non‑competitive inhibition. All reversible inhibitors can be removed by dialysis or dilution, after which the enzyme regains its activity. This experimental distinction helps identify whether an inhibitor is reversible.

可逆抑制进一步分为竞争性、非竞争性和反竞争性模式，不过剑桥国际A‑level大纲主要关注竞争性和非竞争性抑制。所有可逆抑制剂都可以通过透析或稀释除去，之后酶恢复活性。这一实验区分有助于判断抑制剂是否可逆。

3. Competitive Inhibition: Molecular Mechanism | 竞争性抑制的分子机制

A competitive inhibitor resembles the substrate in shape and charge distribution, allowing it to bind to the active site of the enzyme. Once bound, the inhibitor blocks the access of the true substrate, but does not undergo any chemical transformation. Because the inhibitor and substrate compete for the same site, the degree of inhibition depends on the relative concentrations of substrate and inhibitor. At a sufficiently high substrate concentration, the substrate can outcompete the inhibitor, and the maximum reaction rate (Vₘₐₓ) can still be achieved.

竞争性抑制剂在形状和电荷分布上与底物相似，因此能够与酶的活性位点结合。结合后，抑制剂阻碍了真实底物的进入，但本身不发生化学转化。由于抑制剂与底物争夺同一位点，抑制程度取决于底物和抑制剂的相对浓度。当底物浓度足够高时，底物能胜过抑制剂，仍可达到最大反应速率 (Vₘₐₓ)。

A well‑known example is the drug methotrexate, which competes with dihydrofolate for the active site of dihydrofolate reductase and is used in cancer chemotherapy. Another textbook example is malonate, which competes with succinate for the active site of succinate dehydrogenase in the Krebs cycle. In both cases, the inhibitor only forms a transient enzyme‑inhibitor complex.

一个众所周知的例子是药物甲氨蝶呤，它与二氢叶酸竞争二氢叶酸还原酶的活性位点，用于癌症化疗。另一个教科书中的例子是丙二酸，它与琥珀酸竞争柠檬酸循环中琥珀酸脱氢酶的活性位点。在这两种情况下，抑制剂只形成暂时的酶‑抑制剂复合物。

4. Kinetics of Competitive Inhibition | 竞争性抑制的动力学

The presence of a competitive inhibitor alters the apparent Michaelis constant (Kₘ) but does not affect Vₘₐₓ. On a Michaelis–Menten plot, the curve with inhibitor lies to the right of the uninhibited curve, reaching the same plateau at very high substrate concentrations. The apparent Kₘ measured from the half‑Vₘₐₓ point is therefore higher, meaning that more substrate is required to reach half‑maximum velocity.

竞争性抑制剂的存在改变了表观米氏常数 (Kₘ)，但不影响Vₘₐₓ。在米氏方程曲线上，加抑制剂的曲线位于未抑制曲线的右侧，在极高底物浓度时与前者达到同一平台。因此，由半Vₘₐₓ点测得的表观Kₘ增大，意味着需要更多底物才能达到一半的最大速率。

v = Vₘₐₓ [S] / (Kₘ(1 + [I]/Kᵢ) + [S])

The factor (1 + [I]/Kᵢ) quantifies how the inhibitor shifts the affinity. In a Lineweaver–Burk double‑reciprocal plot (1/v against 1/[S]), competitive inhibition gives a set of lines that intersect on the 1/v axis (y‑axis). The slope increases with inhibitor concentration, but the y‑intercept (1/Vₘₐₓ) remains unchanged, confirming that Vₘₐₓ is constant.

因子(1 + [I]/Kᵢ)量化了抑制剂对亲和力的影响。在莱恩威弗‑伯克双倒数图 (1/v 对 1/[S]) 中，竞争性抑制得到一组相交于1/v轴（y轴）的直线。斜率随抑制剂浓度增加而增大，但y轴截距 (1/Vₘₐₓ) 保持不变，证实Vₘₐₓ为常数。

Parameter	No inhibitor	Competitive inhibitor
Vₘₐₓ	Normal	Unchanged
Apparent Kₘ	Kₘ	Increased
Lineweaver–Burk intersection	—	On the 1/v axis

---

5. Non‑competitive Inhibition: Molecular Mechanism | 非竞争性抑制的分子机制

A non‑competitive inhibitor bears no structural resemblance to the substrate and binds to a site different from the active site – an allosteric site. The inhibitor can bind either to the free enzyme or to the enzyme‑substrate complex; in both cases it induces a conformational change that distorts the active site, preventing catalysis. Because the inhibitor does not compete with the substrate for the active site, increasing substrate concentration does not overcome the inhibition.

非竞争性抑制剂在结构上与底物没有相似性，并结合在与活性位点不同的位点——别构位点。抑制剂既可以与游离酶结合，也可以与酶‑底物复合物结合；两种情况下它都会诱导构象变化，使活性位点扭曲，从而阻止催化。因为抑制剂并不与底物争夺活性位点，因此增加底物浓度无法消除抑制。

Many heavy metals act as non‑competitive inhibitors by binding to cysteine –SH groups away from the active site, altering the enzyme’s tertiary structure. Cyanide ion (CN⁻) is a potent non‑competitive inhibitor of cytochrome c oxidase, the final complex in the mitochondrial electron transport chain. This explains its extreme toxicity.

许多重金属作为非竞争性抑制剂，通过与远离活性位点的半胱氨酸‑SH基团结合，改变了酶的三级结构。氰离子 (CN⁻) 是细胞色素c氧化酶——线粒体电子传递链的最后一个复合物——的强效非竞争性抑制剂，这解释了其极强的毒性。

6. Kinetics of Non‑competitive Inhibition | 非竞争性抑制的动力学

Non‑competitive inhibition reduces the functional enzyme concentration, lowering Vₘₐₓ without altering the enzyme’s affinity for the substrate. Consequently, the apparent Kₘ remains unchanged. On a Michaelis–Menten plot, the curve shows a lower plateau, and the half‑saturation point occurs at the same substrate concentration as the uninhibited reaction.

非竞争性抑制降低了功能性酶的浓度，使Vₘₐₓ减小，但不影响酶对底物的亲和力。因此，表观Kₘ保持不变。在米氏方程曲线上，曲线表现为较低的平台，并且半饱和点与未抑制反应在相同的底物浓度处出现。

v = (Vₘₐₓ / (1 + [I]/Kᵢ)) × [S] / (Kₘ + [S])

In a Lineweaver–Burk plot, non‑competitive inhibition produces a family of lines that intersect on the 1/[S] axis (x‑axis). The slope and the y‑intercept both increase with inhibitor concentration, while the x‑intercept (–1/Kₘ) stays the same. This is a powerful diagnostic tool for distinguishing inhibition types in data‑handling questions.

在莱恩威弗‑伯克图中，非竞争性抑制产生一组相交于1/[S]轴（x轴）的直线。斜率和y轴截距均随抑制剂浓度增加而增加，而x轴截距 (–1/Kₘ) 保持不变。这是在数据处理问题中区分抑制类型的强大诊断工具。

Parameter	No inhibitor	Non‑competitive inhibitor
Vₘₐₓ	Normal	Decreased
Apparent Kₘ	Kₘ	Unchanged
Lineweaver–Burk intersection	—	On the 1/[S] axis

---

7. End‑product Inhibition (Feedback Inhibition) | 末端产物抑制（反馈抑制）

Many metabolic pathways are regulated by end‑product inhibition, a form of reversible allosteric inhibition. In this mechanism, the final product of a multistep pathway binds to an allosteric site on the first enzyme, reducing its activity. This prevents the wasteful over‑accumulation of intermediates and conserves resources. Because the inhibitor is structurally distinct from the substrate, this is classified as non‑competitive inhibition.

许多代谢途径通过末端产物抑制进行调控，这是一种可逆的别构抑制。在此机制中，多步骤途径的终产物结合到第一个酶的别构位点，降低其活性。这防止了中间产物的浪费性积累并节约资源。由于抑制剂在结构上与底物明显不同，这被归类为非竞争性抑制。

A classic example is the regulation of glycolysis in mammals. Phosphofructokinase (PFK) is allosterically inhibited by ATP, the end product of cellular respiration. When ATP levels are high, ATP binds to a regulatory site on PFK, reducing its affinity for fructose‑6‑phosphate and slowing down glycolysis. This is a beautiful example of how cells maintain energy homeostasis.

一个经典实例是哺乳动物糖酵解的调控。磷酸果糖激酶 (PFK) 受到细胞呼吸终产物ATP的别构抑制。当ATP水平高时，ATP结合到PFK的调节位点，降低其对果糖‑6‑磷酸的亲和力，从而减慢糖酵解。这是细胞维持能量稳态的一个美妙例子。

8. Irreversible Inhibitors in Medicine and Toxicology | 医学和毒理学中的不可逆抑制剂

Irreversible inhibitors form stable covalent adducts with amino acid side chains in the active site. Penicillin covalently binds to the transpeptidase enzyme involved in bacterial cell wall synthesis, permanently blocking its activity. This is why penicillin is bactericidal. Aspirin (acetylsalicylic acid) irreversibly acetylates a serine residue in cyclooxygenase enzymes, reducing the synthesis of prostaglandins that mediate pain and inflammation.

不可逆抑制剂与活性位点内的氨基酸侧链形成稳定的共价加合物。青霉素与参与细菌细胞壁合成的转肽酶共价结合，永久性阻断其活性，因此青霉素能杀菌。阿司匹林（乙酰水杨酸）不可逆地乙酰化环氧合酶中的一个丝氨酸残基，减少介导疼痛和炎症的前列腺素的合成。

Organophosphate pesticides and nerve gases such as sarin irreversibly inhibit acetylcholinesterase, the enzyme that breaks down the neurotransmitter acetylcholine. The resulting accumulation of acetylcholine in synapses leads to overstimulation of muscles and can be fatal. The distinction between reversible and irreversible inhibition is therefore critical in toxicology and drug design.

有机磷杀虫剂和神经毒气如沙林不可逆地抑制乙酰胆碱酯酶，即分解神经递质乙酰胆碱的酶。乙酰胆碱在突触中累积，导致肌肉过度兴奋，可能致命。因此，可逆与不可逆抑制的区分在毒理学和药物设计中至关重要。

9. Investigating Enzyme Inhibition in the Laboratory | 实验室中的酶抑制研究

Students often investigate the effect of inhibitors by measuring the initial rate of an enzyme‑catalysed reaction at different substrate concentrations, both in the absence and presence of an inhibitor. A common practical uses the enzyme alkaline phosphatase and phosphate ion as a competitive inhibitor. Alternatively, the breakdown of hydrogen peroxide by catalase can be inhibited by copper(II) sulfate, which acts as a non‑competitive inhibitor.

学生常通过测量不同底物浓度下、有和无抑制剂时酶促反应的初始速率来研究抑制剂的作用。一个常见的实验使用碱性磷酸酶，以磷酸根离子作为竞争性抑制剂。另一种实验是利用铜(II)硫酸盐作为非竞争性抑制剂，抑制过氧化氢酶对过氧化氢的分解。

From the collected data, Lineweaver–Burk plots can be drawn to calculate Vₘₐₓ and Kₘ values. Comparing the intercepts and slopes allows students to determine the type of inhibition present. This builds essential data‑analysis skills and reinforces the theoretical models covered in the syllabus.

从收集的数据中，可以绘制莱恩威弗‑伯克图来计算Vₘₐₓ和Kₘ值。比较截距和斜率，学生能够确定存在的抑制类型。这培养了关键的数据分析能力，并巩固了大纲中的理论模型。

10. Summary and Examination Tips | 总结与应试技巧

When tackling enzyme inhibitor questions, start by identifying whether the inhibition is reversible or irreversible. For reversible inhibitors, use the Michaelis–Menten and Lineweaver–Burk frameworks: competitive inhibitors raise apparent Kₘ but leave Vₘₐₓ unchanged; non‑competitive inhibitors lower Vₘₐₓ but leave Kₘ unchanged. End‑product inhibition is a physiological form of non‑competitive inhibition that underpins metabolic regulation.

在处理酶抑制剂问题时，首先要判断是可逆还是不可逆抑制。对于可逆抑制剂，使用米氏方程和莱恩威弗‑伯克图的框架：竞争性抑制剂提高表观Kₘ，但Vₘₐₓ不变；非竞争性抑制剂降低Vₘₐₓ，但Kₘ不变。末端产物抑制是非竞争性抑制的一种生理形式，是代谢调控的基础。

Be ready to interpret graphs, explain molecular mechanisms, and apply your knowledge to novel scenarios, such as drug action or toxin poisoning. Remember to use precise terminology: ‘active site’, ‘allosteric site’, ‘conformational change’, ‘Vₘₐₓ’ and ‘Kₘ’. Practising past paper questions will help you move from memorising facts to demonstrating understanding.

做好准备解读图表、解释分子机制，并将知识应用于新情境，如药物作用或毒素中毒。记得使用精确术语：“活性位点”“别构位点”“构象变化”“Vₘₐₓ”和“Kₘ”。通过练习历年考题，你将能从记忆事实转向展示理解。

Published by TutorHao | Biology Revision Series | aleveler.com

更多咨询请联系16621398022（同微信）